C. Deschaseaux

592 total citations
27 papers, 441 citations indexed

About

C. Deschaseaux is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Family Practice. According to data from OpenAlex, C. Deschaseaux has authored 27 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 13 papers in Economics and Econometrics and 6 papers in Family Practice. Recurrent topics in C. Deschaseaux's work include Heart Failure Treatment and Management (15 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Medication Adherence and Compliance (6 papers). C. Deschaseaux is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Medication Adherence and Compliance (6 papers). C. Deschaseaux collaborates with scholars based in Switzerland, United Kingdom and France. C. Deschaseaux's co-authors include John J.V. McMurray, Michele Senni, Shannon Cope, Amy Earley, Heather Burnett, Adriaan A. Voors, David Trueman, Elizabeth Hancock, Anna Strömberg and Stuart Turner and has published in prestigious journals such as Journal of the American College of Cardiology, Heart and Health and Quality of Life Outcomes.

In The Last Decade

C. Deschaseaux

26 papers receiving 434 citations

Peers

C. Deschaseaux
Javier García Alegría Spain
Yihong Deng United States
Hanna Blackledge United Kingdom
Buthaina Ibrahim Italy
Ayman Hammoudeh Jordan
Stanford Mwasongwe United States
Amr Abdin Germany
Josefina Medina‐Lezama United States
Eva Fhärm Sweden
Roma Puronaitė Lithuania
Javier García Alegría Spain
C. Deschaseaux
Citations per year, relative to C. Deschaseaux C. Deschaseaux (= 1×) peers Javier García Alegría

Countries citing papers authored by C. Deschaseaux

Since Specialization
Citations

This map shows the geographic impact of C. Deschaseaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Deschaseaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Deschaseaux more than expected).

Fields of papers citing papers by C. Deschaseaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Deschaseaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Deschaseaux. The network helps show where C. Deschaseaux may publish in the future.

Co-authorship network of co-authors of C. Deschaseaux

This figure shows the co-authorship network connecting the top 25 collaborators of C. Deschaseaux. A scholar is included among the top collaborators of C. Deschaseaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Deschaseaux. C. Deschaseaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Burnett, Heather, Amy Earley, Adriaan A. Voors, et al.. (2017). Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction. Circulation Heart Failure. 10(1). 166 indexed citations
4.
Strömberg, Anna, Nicola Bonner, Laura Grant, et al.. (2017). Psychometric Validation of the Heart Failure Caregiver Questionnaire (HF-CQ®). Patient. 10(5). 579–592. 16 indexed citations
5.
Ademi, Zanfina, Alena M. Pfeil, Elizabeth Hancock, et al.. (2017). Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Swiss Medical Weekly. 147(4546). w14533–w14533. 27 indexed citations
6.
Ademi, Zanfina, Elizabeth Hancock, David Trueman, et al.. (2016). Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland. Value in Health. 19(7). A655–A655. 1 indexed citations
7.
Deschaseaux, C., et al.. (2016). Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis. Journal of Managed Care & Specialty Pharmacy. 22(5). 561–571. 37 indexed citations
8.
Mantovani, LG, et al.. (2016). Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy. Value in Health. 19(7). A650–A650. 1 indexed citations
9.
Gaziano, Thomas A., Gregg C. Fonarow, Brian Claggett, et al.. (2016). A COST-EFFECTIVENESS ANALYSIS IN THE US OF LCZ696 (SACUBITRIL/VALSARTAN) VERSUS RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 67(13). 1302–1302. 2 indexed citations
10.
11.
McMurray, John J.V., Martín Cowie, Andrew Briggs, et al.. (2015). A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction. Value in Health. 18(7). A394–A394. 2 indexed citations
12.
Gwaltney, Chad, B. Tiplady, & C. Deschaseaux. (2015). Using The Clinical Summary Score From The Kansas City Cardiomyopathy Questionnaire As An Endpoint In Clinical Trials: Psychometric Support. Value in Health. 18(3). A24–A24. 1 indexed citations
13.
Webb, Nicholas J.A., Martín Cowie, Andrew Briggs, et al.. (2015). The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review. Value in Health. 18(7). A391–A391. 1 indexed citations
14.
15.
Nafees, Beenish, et al.. (2014). Health State Utilities In Chronic Heart Failure In The Uk. Value in Health. 17(7). A493–A493. 3 indexed citations
16.
Chiva-Razavi, Sima, et al.. (2014). Real-World Health Care Resource Utilisation Among Patients With Chronic Heart Failure: A Canadian Assessment. Value in Health. 17(3). A119–A119.
17.
18.
Bouée, S., et al.. (2013). Costs of Acute Heart Failure in France. Value in Health. 16(7). A521–A521. 1 indexed citations
19.
Stålhammar, Jan, Lee Stern, Rohan Parikh, et al.. (2013). The burden of preserved ejection fraction heart failure in a real-world Swedish patient population. Journal of Medical Economics. 17(1). 43–51. 18 indexed citations
20.
Blackburn, Steven, et al.. (2012). PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure: A Qualitative Study. Value in Health. 15(7). A378–A378. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier García Alegría Breakdown of academic impact, for papers by Yihong Deng Breakdown of academic impact, for papers by Hanna Blackledge Breakdown of academic impact, for papers by Buthaina Ibrahim Breakdown of academic impact, for papers by Ayman Hammoudeh Breakdown of academic impact, for papers by Stanford Mwasongwe Breakdown of academic impact, for papers by Amr Abdin Breakdown of academic impact, for papers by Josefina Medina‐Lezama Breakdown of academic impact, for papers by Eva Fhärm Breakdown of academic impact, for papers by Roma Puronaitė
Rankless by CCL
2026